{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:16:47Z","timestamp":1793121407490,"version":"4.5.0"},"reference-count":72,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Klotho is a longevity-associated and tissue-protective protein involved in mineral metabolism, oxidative stress, inflammation, fibrosis, cellular senescence, and neurovascular homeostasis. However, nearly three decades after its discovery, no Klotho-based therapy has been approved, highlighting a translational gap that extends beyond biological validation. This review reframes Klotho translation as a pharmaceutical sciences challenge, focusing on how to convert Klotho into a druggable, manufacturable, deliverable, and clinically controllable therapeutic product. We summarize the isoform-specific properties of membrane-bound \u03b1-Klotho, soluble \u03b1-Klotho, and \u03b2-Klotho that are relevant to product design, and review the current clinical and preclinical landscape dominated by gene-, mRNA-, and antibody-based approaches. We further distinguish confirmed developability barriers, including renal handling and limited systemic persistence, from plausible risks common to macromolecular biologics, such as aggregation, chemical degradation, immunogenicity, and poor tissue penetration. Finally, we evaluate emerging delivery and formulation strategies, including viral and non-viral gene delivery, extracellular vesicles, hydrogels, ultrasound-targeted microbubbles, osmotic pumps, and long-acting protein engineering. An integrated roadmap combining molecular engineering, disease-specific delivery, pharmacokinetic\/pharmacodynamic biomarkers, manufacturability assessment, and repeated-dose safety evaluation may help transform Klotho from a promising anti-aging molecule into a clinically viable biologic platform.<\/jats:p>","DOI":"10.3390\/pharmaceutics18091124","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:23:37Z","timestamp":1788773017000},"page":"1124","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmaceutical Strategies for Translating Klotho-Based Therapeutics: From Biologic Developability to Advanced Delivery Systems"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1396-0659","authenticated-orcid":false,"given":"Lingxin","family":"Zeng","sequence":"first","affiliation":[{"name":"School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7350-5536","authenticated-orcid":false,"given":"Xuan","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Matsumura","year":"1997","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Buchanan, S., Combet, E., Stenvinkel, P., and Shiels, P.G. (2020). Klotho, aging, and the failing kidney. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00560"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","article-title":"The Klotho proteins in health and disease","volume":"15","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00424-009-0722-7","article-title":"Klotho","volume":"459","year":"2010","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MNH.0b013e3282ffd994","article-title":"The Klotho gene family and the endocrine fibroblast growth factors","volume":"17","author":"Kurosu","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Aaldijk, A.S., Verzijl, C.R.C., Jonker, J.W., and Struik, D. (2023). Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1150222"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature25010","article-title":"Structures of \u03b2-klotho reveal a \u2018zip code\u2019-like mechanism for endocrine FGF signalling","volume":"553","author":"Lee","year":"2018","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ymthe.2019.11.013","article-title":"Urinary extracellular vesicles carrying Klotho improve the recovery of renal function in an acute tubular injury model","volume":"28","author":"Grange","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.kint.2016.10.034","article-title":"Recombinant alpha-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy","volume":"91","author":"Hu","year":"2017","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1681\/ASN.2015111266","article-title":"Chronic hyperphosphatemia and vascular calcification are reduced by stable delivery of soluble Klotho","volume":"28","author":"Hum","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Prud\u2019homme, G.J., Kurt, M., and Wang, Q. (2022). Pathobiology of the Klotho antiaging protein and therapeutic considerations. Front. Aging, 3.","DOI":"10.3389\/fragi.2022.931331"},{"key":"ref_12","first-page":"101629","article-title":"Klotho in age-related cardiovascular diseases: Insights into mitochondrial dysfunction and cell death","volume":"57","author":"Mehri","year":"2025","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s43556-025-00253-y","article-title":"Klotho antiaging protein: Molecular mechanisms and therapeutic potential in diseases","volume":"6","author":"Hajare","year":"2025","journal-title":"Mol. Biomed."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1681\/ASN.0000000000000388","article-title":"Klotho: A large protein with various beneficial functions, but also with therapeutic value?","volume":"35","author":"Yanucil","year":"2024","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_15","unstructured":"Minicircle (2026, August 19). Safety and Efficacy of Klotho and Follistatin Gene Therapy. Available online: https:\/\/ichgcp.net\/clinical-trials-registry\/NCT07285629."},{"key":"ref_16","unstructured":"Minicircle (2026, August 19). Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans. Available online: https:\/\/ichgcp.net\/clinical-trials-registry\/NCT07216781."},{"key":"ref_17","unstructured":"CSPC Pharmaceutical Group (2026, August 19). CSPC\u2019s Recombinant Fully Human Anti-\u03b2Klotho Monoclonal Antibody Approved for Clinical Trials. Available online: https:\/\/www.e-cspc.com\/details\/details_92_5394.html."},{"key":"ref_18","unstructured":"eMedClub News (2026, August 19). Star Longevity Gene Therapy Company Klotho Expands its Footprint, Shifting the Anti-Aging Paradigm from Single-Disease Treatment to Systemic Intervention. Available online: https:\/\/www.sohu.com\/a\/917702764_120088173."},{"key":"ref_19","unstructured":"Klotho Neurosciences (2026, August 19). US FDA Grants Orphan Drug Designation to Klotho Neurosciences\u2019 KLTO-202 to Treat Amyotrophic Lateral Sclerosis. Available online: https:\/\/www.familydoctor.cn\/news\/meiguo-fda-shouyu-guer-zige-jiandongzheng-146770.html."},{"key":"ref_20","unstructured":"Jocasta Neuroscience (2026, August 19). Jocasta Neuroscience Lands $35 Million Series a to Advance Longevity Protein Program for Managing Cognitive Impairment. Available online: https:\/\/www.familydoctor.cn\/news\/kasita-shenjingkexue-wanmeiyuan-a-tui-changshou-liaofa-177926.html."},{"key":"ref_21","unstructured":"Klothea Bio Inc (2026, August 19). aKLmRNA-Mediated Protein Replacement Therapy, Available online: https:\/\/clinicaltrials.gov\/study\/NCT07544420."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Saar-Kovrov, V., Donners, M.M.P.C., and van der Vorst, E.P.C. (2020). Shedding of Klotho: Functional implications in chronic kidney disease and associated vascular disease. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.617842"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chen, C.-D., Li, Y., Chen, A.K., Rudy, M.A., Nasse, J.S., Zeldich, E., Polanco, T.J., and Abraham, C.R. (2020). Identification of the cleavage sites leading to the shed forms of human and mouse anti-aging and cognition-enhancing protein Klotho. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0226382"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41586-023-06155-9","article-title":"Structural basis for FGF hormone signalling","volume":"618","author":"Chen","year":"2023","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-physiol-021119-034650","article-title":"Regulation and effects of FGF23 in chronic kidney disease","volume":"82","author":"Musgrove","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Prud\u2019homme, G.J., and Wang, Q. (2024). Anti-inflammatory role of the Klotho protein and relevance to aging. Cells, 13.","DOI":"10.20944\/preprints202408.0213.v1"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Donate-Correa, J., Mart\u00edn-Carro, B., Cannata-And\u00eda, J.B., Mora-Fern\u00e1ndez, C., and Navarro-Gonz\u00e1lez, J.F. (2023). Klotho, oxidative stress, and mitochondrial damage in kidney disease. Antioxidants, 12.","DOI":"10.3390\/antiox12020239"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/978-1-4614-0887-1_7","article-title":"Regulation of ion channels by secreted Klotho","volume":"728","author":"Huang","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1038\/s41598-023-31117-6","article-title":"Differential toxicity profile of secreted and processed \u03b1-Klotho expression over mineral metabolism and bone microstructure","volume":"13","author":"Abraham","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.33594\/000000797","article-title":"Regulation of \u03b1Klotho","volume":"59","author":"Vogt","year":"2025","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_31","first-page":"103458","article-title":"Klotho: A multifaceted protector in sepsis-induced organ damage and a potential therapeutic target","volume":"14","author":"Anter","year":"2025","journal-title":"World J. Crit. Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kang, J.S., Son, S.S., Lee, J.-H., Lee, S.W., Jeong, A.R., Lee, E.S., Cha, S.-K., Chung, C.H., and Lee, E.Y. (2021). Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0250666"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e2972","DOI":"10.1038\/cddis.2017.365","article-title":"Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K\/AKT pathway during tacrolimus-induced oxidative stress","volume":"8","author":"Lim","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Mohammad, G.H., Kieswich, J., Kumar, A., McCafferty, K., Chakraborty, R., Thiemermann, C., and Yaqoob, M.M. (2025). Artesunate alleviates kidney fibrosis by restoring klotho protein and suppressing Wnt\/\u03b2-catenin signalling pathway. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1688753"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Li, S., Yu, L., He, A., and Liu, Q. (2019). Klotho inhibits unilateral ureteral obstruction-induced endothelial-to-mesenchymal transition via TGF-\u03b21\/Smad2\/Snail1 signaling in mice. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00348"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.addr.2017.07.009","article-title":"Effects of Klotho on fibrosis and cancer: A renal focus on mechanisms and therapeutic strategies","volume":"121","author":"Mencke","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13041-025-01199-6","article-title":"Klotho overexpression protects human cortical neurons from \u03b2-amyloid induced neuronal toxicity","volume":"18","author":"Shaker","year":"2025","journal-title":"Mol. Brain"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e13239","DOI":"10.1111\/acel.13239","article-title":"Klotho overexpression improves amyloid-\u03b2 clearance and cognition in the APP\/PS1 mouse model of Alzheimer\u2019s disease","volume":"19","author":"Zhao","year":"2020","journal-title":"Aging Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.celrep.2014.03.076","article-title":"Life extension factor klotho enhances cognition","volume":"7","author":"Dubal","year":"2014","journal-title":"Cell Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.20517\/jca.2024.16","article-title":"The aging heart: Exploring the role of Klotho in cardiac health\/function","volume":"4","author":"Daneshgar","year":"2024","journal-title":"J. Cardiovasc. Aging"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Palamar, M., Grosu Radulescu, I.D., Tanasescu, M.D., Sircuta, A., and Bob, F. (2025). Vascular calcification in chronic kidney disease and hemodialysis: Pathophysiological mechanisms and emerging biomarkers. Medicina, 61.","DOI":"10.3390\/medicina61122169"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41569-023-00903-0","article-title":"FGF23 and klotho at the intersection of kidney and cardiovascular disease","volume":"21","author":"Edmonston","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115179","DOI":"10.1016\/j.fct.2024.115179","article-title":"Renoprotective effect of berberine in cisplatin-induced acute kidney injury: Role of Klotho and the AMPK\/mtor\/ULK1\/Beclin-1 pathway","volume":"196","author":"Salah","year":"2025","journal-title":"Food Chem. Toxicol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yjmcc.2025.09.004","article-title":"Klotho attenuates D-galactose-induced cardiac aging through the ROS\/NLRP3\/pyroptosis pathway","volume":"208","author":"Wang","year":"2025","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.17219\/acem\/184639","article-title":"Recombinant Klotho protein protects pulmonary alveolar epithelial cells against sepsis-induced apoptosis by inhibiting the Bcl-2\/Bax\/caspase-3 pathway","volume":"34","author":"Li","year":"2025","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"117608","DOI":"10.1016\/j.biopha.2024.117608","article-title":"\u03b2-Klotho as novel therapeutic target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A narrative review","volume":"180","author":"Meroni","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"F359","DOI":"10.1152\/ajprenal.00240.2014","article-title":"Shedding of klotho by ADAMs in the kidney","volume":"309","author":"Pulskens","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhao, X., Han, D., Zhao, C., Yang, F., Wang, Z., Gao, Y., Jin, M., and Tao, R. (2024). New insights into the role of Klotho in inflammation and fibrosis: Molecular and cellular mechanisms. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1454142"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0701600104","article-title":"BetaKlotho is required for metabolic activity of fibroblast growth factor 21","volume":"104","author":"Ogawa","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/me.2007-0313","article-title":"betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c","volume":"22","author":"Suzuki","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1681\/ASN.2014101030","article-title":"Renal production, uptake, and handling of circulating alphaKlotho","volume":"27","author":"Hu","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1074\/jbc.RA119.012144","article-title":"Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease","volume":"295","author":"Zhong","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/1520-6017(200103)90:3<310::AID-JPS6>3.0.CO;2-R","article-title":"A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody","volume":"90","author":"Cleland","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"103771","DOI":"10.1016\/j.xphs.2025.103771","article-title":"Highly variable aggregation and glycosylation profiles and their roles in immunogenicity to protein-based therapeutics","volume":"114","author":"Sarsarshahi","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"125774","DOI":"10.1016\/j.ijpharm.2025.125774","article-title":"Subvisible particle formation under mechanical and interfacial stress: A case study using bovine serum albumin as a model for biotherapeutic proteins","volume":"680","author":"Eshraghi","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1021\/acs.molpharmaceut.0c01113","article-title":"Adsorption and aggregation of monoclonal antibodies at silicone oil-water interfaces","volume":"18","author":"Kannan","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s11095-024-03726-x","article-title":"Stability of protein pharmaceuticals: Recent advances","volume":"41","author":"Manning","year":"2024","journal-title":"Pharm. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.xphs.2015.11.002","article-title":"Immunogenicity of therapeutic protein aggregates","volume":"105","author":"Moussa","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1263\/jbb.101.203","article-title":"Immunogenic and allergenic potentials of natural and recombinant innocuous proteins","volume":"101","author":"Matsuda","year":"2006","journal-title":"J. Biosci. Bioeng."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3892\/mmr.2015.3367","article-title":"Klotho gene delivery ameliorates renal hypertrophy and fibrosis in streptozotocin-induced diabetic rats by suppressing the Rho-associated coiled-coil kinase signaling pathway","volume":"12","author":"Deng","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2018.03.027","article-title":"Lentivirus-mediated klotho up-regulation improves aging-related memory deficits and oxidative stress in senescence-accelerated mouse prone-8 mice","volume":"200","author":"Zhou","year":"2018","journal-title":"Life Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12951-025-03499-4","article-title":"The effects of Klotho delivering mesenchymal stem cell-derived small extracellular vesicles on acute kidney injury","volume":"23","author":"Deng","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"0099","DOI":"10.34133\/bmr.0099","article-title":"An in situ sustained-release chitosan hydrogel to attenuate renal fibrosis by retaining Klotho expression","volume":"28","author":"Li","year":"2024","journal-title":"Biomater. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"eadm7164","DOI":"10.1126\/sciadv.adm7164","article-title":"Bioactive fiber-reinforced hydrogel to tailor cell microenvironment for structural and functional regeneration of myotendinous junction","volume":"10","author":"Sun","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"122926","DOI":"10.1016\/j.biomaterials.2024.122926","article-title":"Nanoparticle-mediated Klotho gene therapy prevents acute kidney injury to chronic kidney disease transition through regulating PPARalpha signaling in renal tubular epithelial cells","volume":"315","author":"Li","year":"2025","journal-title":"Biomaterials"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3892\/ijmm.2024.5378","article-title":"Ultrasound-targeted microbubble destruction technology delivering beta-klotho to the heart enhances FGF21 sensitivity and attenuates heart remodeling post-myocardial infarction","volume":"53","author":"Yue","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3892\/mmr.2017.6661","article-title":"Enhanced effect of nuclear localization signal peptide during ultrasound-targeted microbubble destruction-mediated gene transfection","volume":"16","author":"Cao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Mrsny, R.J., and Mahmood, T.A. (2021). Re-assessing PK\/PD issues for oral protein and peptide delivery. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13071006"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4155\/tde.11.128","article-title":"Opportunities and challenges for oral delivery of hydrophobic versus hydrophilic peptide and protein-like drugs using lipid-based technologies","volume":"2","author":"Griffin","year":"2011","journal-title":"Ther. Deliv."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41467-022-28096-z","article-title":"A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-\u03b2 signaling","volume":"13","author":"Yuan","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7150\/thno.89105","article-title":"Klotho-derived peptide 1 inhibits cellular senescence in the fibrotic kidney by restoring Klotho expression via posttranscriptional regulation","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Basak, S. (2026). Artificial intelligence and machine learning-guided bio-orthogonal engineering of smart soft polymeric nanocarriers for precision drug delivery and translational nanomedicine. Front. Soft Matter, 6.","DOI":"10.3389\/frsfm.2026.1883618"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1124\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:29:55Z","timestamp":1788773395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":72,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["pharmaceutics18091124"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18091124","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}